Evidence map›Paper›PMID 34078154›Full record

ArticleLupus2021

Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus.

Michelle Quilter, Linda Hiraki, Andrea M Knight, Julie Couture, Deborah Levy, Earl D Silverman, Ashley N Danguecan, Lawrence Ng, Daniela Dominguez, Katherine T Cost and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Lupus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michelle QuilterDepartment of Psychiatry, The Hospital for Sick Children, Toronto, Canada.ORCID https://orcid.org/0000-0002-3155-6031
Linda HirakiDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Andrea M KnightDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Julie CoutureDivision of Pediatric Rheumatology-Immunology, CHU Sainte-Justine, Montreal, Canada.
Deborah LevyDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Earl D SilvermanDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Ashley N DanguecanDepartment of Psychology, The Hospital for Sick Children, Toronto, Canada.
Lawrence NgDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Daniela DominguezDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Katherine T CostDepartment of Psychiatry, The Hospital for Sick Children, Toronto, Canada.
Kate M NeufeldDivision of Rheumatology, The Hospital for Sick Children, Toronto, Canada.
Reva SchachterDepartment of Psychiatry, The Hospital for Sick Children, Toronto, Canada.
Daphne J KorczakDepartment of Psychiatry, The Hospital for Sick Children, Toronto, Canada.
University of Toronto · CAHospital for Sick Children · CACentre Hospitalier Universitaire Sainte-Justine · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are no validated screening measures for depressive or anxiety disorders in childhood Systemic Lupus Erythematosus (cSLE). We investigated cross-sectionally (1) the prevalence of depressive and anxiety disorder in cSLE. (2) the validity of the Centre for Epidemiologic Studies Depression Scale for Children (CES-DC) and the Screen for Childhood Anxiety and Related Disorders (SCARED) measures in identifyingthese disorders.

methodsParticipants 8-18 years with cSLE/incipient cSLE completed CES-DC, SCARED, and Quality OfMy Life (QOML) measures. Parents completed the SCARED-Parent measure. Diagnosis was by gold-standard psychiatric interview and determined prevalence of psychiatric disorder. Receiver Operating Characteristics Area under the Curve (ROCAUC) evaluated screening measure diagnostic performance.

resultsOfseventy-two parent-child dyads, 56 interviews were completed. Mean screen scores were: CES-DC = 15 (range 1-49, SD 12), SCARED-C = 22 (range 2-61, SD 14), SCARED-P = 13 (range 0-36, SD 8). Depressive disorder screen positivity (CES-DC ≥ 15) was 35% (vs. prevalence 5%). Anxiety disorder screen positivity (SCARED ≥ 25) was 39% (vs. prevalence 16%). CES-DC ROCAUC = 0.98 and SCARED-C ROCAUC = 0.7 (cut-points 38 and 32 respectively).

conclusionsDiagnostic thresholds for depressive and anxiety disorderscreening measures are high for both CES-DC and SCARED-C in cSLE. Brief focused interview should follow to determine whether psychiatric evaluation is warranted.

Indexed as

Lupus Erythematosus, SystemicAdolescentAnxietyAnxiety DisordersHumansMass ScreeningSelf ReportanxietyDepressionpediatricscreeningsystemic lupus erythematosus

Identifiers

PMID34078154
PMCPMC8209764
OpenAlexW3165632540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.